Written question asked by Lord Campbell-Savours (Labour) on Monday, 25 January 2021, in the House of Lords. It was due for an answer on Monday, 8 February 2021. It was answered by Lord Callanan (Conservative) on Monday, 8 February 2021 on behalf of the Department for Business, Energy and Industrial Strategy.
Coronavirus: Vaccination
- Question
-
To ask Her Majesty's Government, further to the Written Answer by Lord Callanan on 21 January (HL11869), with which companies they have entered into any contracts relating to the production of COVID-19 vaccines; and what plans they have to make the terms of those contracts available to the public.
- Answer
-
The UK Government has secured early access to 457 million vaccines doses through agreements with eight separate vaccine developers. This includes agreements with BioNTech/Pfizer, University of Oxford/AstraZeneca, GlaxoSmithKline/Sanofi Pasteur, Novavax, Janssen, Valneva, Moderna and CureVac.
In addition to the above, we have also funded fill and finish capability through a contract with Wockhardt in Wrexham, North Wales, as well as the expansion of the Valneva factory in Livingston, Scotland.
Secondary information
- Type
- Written question
- Reference
- HL12477
- Session
- 2019-21
- Related items
- Subjects
- Contracts Vaccination Coronavirus
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2021-02-08 17:44:33 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2019-21/HL12477
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2019-21/HL12477
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2019-21/HL12477